Connect with us

Emerging Markets

Cyberlux Corp (OTCMKTS: CYBL) Breakout Out Northbound as DOD Contractor Reports Record Revenues, New Acquisitions & 700 million Share Elimination

Published

1 year ago

on

Cyberlux Corp (OTCMKTS: CYBL) has been heating up in recent trading and the stock is breaking northbound since a brief dip below the $0.01 mark in February. Volume has been picking up too with CYBL trading $1.5 million in dollar volume on Thursday alone. CYBL has a large international following of investors that was instrumental when the stock skyrocketed in 2021 from subs in April to highs of $0.066 in September. They are accumulating at current levels and a move back to previous highs; a break over $0.066 and its blue skies ahead for CYBL.  The timing on CYBL seems perfect as the Company completes the next in a long line of acquisitions with the acquisition of Catalyst Machineworks, LLC, a leader in the highly technical cinematography drone market with established product lines that address the high-end military-grade market, the specialized drone racing market and the high-volume consumer market. This comes on the heels of significant growth through acquisitions across industries with advanced unmanned aircraft systems (UAS), LED lighting solutions, renewable energy and infrastructure technology, and Software-as-a-Service (SaaS) solutions.   

The big story on CYBL is the record revenues the Company keeps reporting month after month easily beating out previous targets. In February revenues were a record $2.12 million representing an 11% increase over January revenues also a record month. Management expects the quarterly revenue growth to continue during 2022 and beyond, as the Company achieves its 2022 revenue outlook of $44.8 million and generates a substantial positive net income from Operations for the year. Cyberlux continues to see growth across all of its business units. Over the last six months, the addition of the FlightEye drone team with GM Larson Isely, the infrastructure business with the FBD Group and the HAVAS team, the Digital Platform Solutions team under GM Igor Stanisavljev with both the Kreatx and the DAS teams, and the stellar Chris Damvakaris as Chief Revenue Officer, is driving the Cyberlux company forward as a global enterprise. CYBL management recently reported they expect to see further acquisitions opening markets which will yield over $200 million in Cyberlux revenue by 2025. 

Cyberlux Corp (OTCMKTS: CYBL) operating out of Research Triangle Park, North Carolina is an advanced technology platform company driving growth through acquisitions, joint ventures and organic growth in the Unmanned Aircraft Systems (UAS), Advanced Lighting Systems, Infrastructure Technology and Software & Services markets. The Company’s customers are U.S. agencies, including the Department of Defense (DoD), State and Local governments, select OEM commercial markets, and global customers across North and South America and Europe. Cyberlux is a recognized leader within the Department of Defense marketplace for solid-state LED lighting innovation. The Company has developed LED lighting technology that is among the most energy efficient and cost effective portable tactical lighting available today for Department of Defense/military and commercial uses. Cyberlux owns a valuable intellectual property portfolio including five U.S. Patents and two pending patents for Portable Lighting Devices and Multi-Mode Illumination. The Company also has three new patent filings for UAS technology in process and anticipates at least three new patent filings for technology developments in conjunction with Cyberlux Strategic Suppliers, and at least two patentable filings for technology development in the advanced remote sensor field of use.  

Cyberlux manufactures BrightEye Tactical Lighting Systems for various U.S. Government agencies including the U.S. Air Force, Air/Army National Guard, U. S. Special Operations Command (USSOCOM), U.S. Army and the Defense Logistics Agency customers. The Company has introduced LED solar street lighting product offerings with a full range of capabilities from 40 watt to 150 watts. The Cyberlux Solar All-In-One (SAIO) LED street lighting is available as Cyberlux SAIO-40 to SAIO-150. Cyberlux also introduced the Cyberlux Solar Power Systems solar power generation offerings, as the 300 watt Cyberlux SPS-300, the 370 watt Cyberlux SPS-370, and the top-of-the-line Cyberlux SPS-440, an industry-leading 440 watts of power production. Currently Cyberlux has pending contracts for 6200 units of the BrightEye Tactical Lighting System from various DoD agencies.  

Cyberlux has a south American office in Bogota and is pursuing business in Colombia with certain commercial companies and government organizations. The Company has developed solar power designs and infrastructure plans for five Colombia projects. As the pandemic comes to an end Cyberlux plans to grow through acquisitions and expand its capabilities significantly with the plan to use its Bogota headquarters operation to extend its business development reach to other South American markets such as Guatemala, Ecuador, El Salvador and Brazil.  

To Find out the inside Scoop on CYBL Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

CYBL

During Q3 2021, Cyberlux closed its first acquisition of a UAS technology and intellectual property stealth works firm, CTMC Drone Solution giving the Company a competitive advantage with the FlightEye hardware and FlightGDN software offerings. CYBL management state they expect to see further acquisitions opening markets which will yield over $200 million in Cyberlux revenue by 2025. 

Cyberlux revenues have been increasing quickly. In February revenues were a record $2.12 million representing an 11% increase over January revenues also a record month. Management expects the quarterly revenue growth to continue during 2022 and beyond, as the Company achieves its 2022 revenue outlook of $44.8 million and generates a substantial positive net income from Operations for the year. The Company continues to see growth across all of its business units. Over the last six months, the addition of the FlightEye drone team with GM Larson Isely, the infrastructure business with the FBD Group and the HAVAS team, the Digital Platform Solutions team under GM Igor Stanisavljev with both the Kreatx and the DAS teams, and the stellar Chris Damvakaris as Chief Revenue Officer, is driving the Cyberlux company forward as a global enterprise. 

Cyberlux continues to make big moves in recent months; they formed a new Channel Business Partnership with The ARG Group, LLC to drive and accelerate the revenue growth. The Company launched the Digital Platform Solutions (DPS) business development and sales efforts with the first wave of target companies and industries, with the mission to drive both end-to-end PaaS and SaaS offerings to global government, military, and commercial customers. Cyberlux South American team completed the engineering plan for the 31-hectare renewable energy generation project and submitted to the Colombian government agencies for approval. The team is also in early-stage development of the Company’s next potential solar farm in the Manizales, Colombia area. Also, the Company’s ITS team is in the final phase of the $47 million U.S. infrastructure opportunity selection. Further, Cyberlux ITS business unit reported on a European project being executed by the Company’s FBD team. This $3+ million project covers 40 miles of electrical grid and fiber optics communications infrastructure construction. 

On March 30 CYBL announced the acquisition of Catalyst Machineworks, LLC, a leader in the highly technical cinematography drone market with established product lines that address the high-end military-grade market, the specialized drone racing market and the high-volume consumer market. Based in Texas, Catalyst Machineworks (CMW) is a leading United States-based drone hardware manufacturer with the intellectual property, technology know-how and production capabilities to deliver true military-grade and law enforcement drone solutions as 100% Made-In-America. 

Microcapdaily first reported on CYBL on July 11 when the stock was trading for well under a penny.

 For More on CYBL Subscribe Right Now!

Currently trading at a $86 million market valuation CYBL has 5,834,750,677 shares outstanding. The Company is in the process of eliminating 700 million shares recently reporting final paperwork has been agreed to, executed and on the way to the transfer agent for action by end of next week. This comes after CYBL enacted a no reverse split policy and dropped the AS from 20 billion down to 8.75 billion and went “pink current.” Cyberlux carries $9.6 million in liabilities on the books some of which is convertible into free trading CYBL. But this is an exciting story developing in small caps; the Company continues to see rapid growth through acquisitions, joint ventures and organic growth in the Unmanned Aircraft Systems (UAS), Advanced Lighting Systems, Infrastructure Technology and Software & Services markets. Cyberlux is a recognized leader within the Department of Defense marketplace for solid-state LED lighting innovation. The Company has developed LED lighting technology that is among the most energy efficient and cost effective portable tactical lighting available today for Department of Defense/military and commercial uses. Currently Cyberlux has pending contracts for 6200 units of the BrightEye Tactical Lighting System from various DoD agencies. We will be updating on CYBL when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with CYBL.

Disclosure: we hold no position in CYBL either long or short and we have not been compensated for this article.

Related Topics:
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Emerging Markets

Aclarion Inc (NASDAQ: ACON): A Breakthrough Partnership

Published

5 days ago

on

May 31, 2023

By

Aclarion, Inc. (NASDAQ: ACON) shares rocketed 157% Tuesday morning after their commercialization agreement with the London Clinic.

Aclarion, Inc. (NASDAQ: ACON) shares rocketed 157% Tuesday morning after their commercialization agreement with the London Clinic. The London Clinic is UK’s most renowned independent, private hospital, established 1932 with their Spine Clinic being the first specialist spinal unit based in England back in 1997.

“With a focus on providing the very best healthcare outcomes, The London Clinic is an ideal customer for Aclarion as the company works to deliver the Nociscan solution to physicians and patients around the world,” said John Sutcliffe MD, Neurosurgeon and Founder of London Spine Clinic. “The engagement with Aclarion will allow London Spine Clinic to continue offering the high-quality care our patients have come to expect. Patients need a careful assessment, diagnosis, and understanding of the different treatment options. Aclarion’s innovative Nociscan solution will enable us to objectively assess biomarkers associated with low back pain and enhance the precision of each diagnosis.”

More on Nociscan Technology

Aclarion, Inc.’s Nociscan Technology is an innovative medical solution that aims to revolutionize the diagnosis of disc-related conditions. They leverage biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain.

What’s exciting is its advantages over the current standard of care. It offers a non-invasive approach, ensuring patient comfort and safety. Given it’s non-invasive, that also means 0 pain with 0 radiation (typically associated with traditional discography). The best part is it can seamlessly integrate into standard lumbar MRI protocols, making it a convenient and efficient option for healthcare providers. 

To Discover the Inside Scoop on ACON, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

The procedure takes approximately 25-45 minutes, thoroughly evaluating spinal discs without compromising accuracy. Additionally, Nociscan technology offers significant cost savings, with a list price of $1,450, making it an affordable alternative to traditional discograms. Overall, Aclarion, Inc.’s technological advances represent a significant push forward in disc-related diagnostic techniques, prioritizing patient well-being, convenience, and affordability.

https://twitter.com/TigerLineTrades/status/1663527784143093762?s=20

Nociscan Study

They also recently completed a study that spanned two years and involved 78 patients at a single site. The success rate soared to an impressive 85% for patients whose treatment strategy aligned with the disks identified by Nociscan. This represented a remarkable 22% improvement over patients whose treatment strategy did not consider the insights provided by Nociscan.

Aclarion expressed confidence that the results of the trial demonstrate the potential of Nociscan to assist physicians in successfully treating DLBP. Dr. Matthew Gornet, orthopedic surgeon and lead author of the study, enthusiastically endorsed Nociscan, stating, “The two-year surgical outcomes of the clinical trial provide unequivocal evidence of its effectiveness, particularly with regards to the primary endpoint, the Oswestry Disability Index (ODI). I firmly believe that Nociscan has the potential to revolutionize the standard of care and accurately aid all physicians treating chronic low back pain.”

It is worth noting that although Nociscan was performed on all patients in the study, it was not part of the surgical decision-making process, as highlighted by the company.

Conclusion

The commercial agreement between Aclarion, Inc. and the prestigious London Clinic signifies a significant milestone for both parties, carrying the potential for global recognition, revenue growth, and scalability. By integrating Aclarion’s innovative Nociscan Technology, the London Clinic demonstrates its commitment to delivering cutting-edge healthcare to optimize patient well-being and enhance clinical outcomes. Furthermore, the partnership’s success holds the potential for scaling Nociscan Technology to other institutions and markets, propelling Aclarion, Inc. to become a global leader in non-invasive medical technologies while driving substantial revenue growth.

We will update you on ACON when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by PIRO from Pixabay

Continue Reading

Emerging Markets

Aemetis Inc. (NASDAQ: AMTX) Pioneers Renewable Fuel Market with EPA Approval

Published

2 weeks ago

on

May 21, 2023

By

Aemetis (NASDAQ: AMTX) shares surged 105% this week. The renewable natural gas and renewable fuels company received approval from the EPA.

Aemetis, Inc. (NASDAQ: AMTX) shares surged 105% this week. The renewable natural gas and renewable fuels company received approval from the U.S. EPA to generate renewable identification numbers (RINs) under the federal Renewable Fuel Standard. They have six dairy biogas digesters up and running, with a seventh one scheduled to start operating in June 2023.

Aemetis plans to generate multiple sources of revenue from its renewable natural gas. They will sell the gas to replace petroleum diesel in transportation, sell California Low Carbon Fuel Standard credits to fuel blenders who need to meet carbon reduction requirements in California, sell the RINs generated under the federal Renewable Fuel Standard, and benefit from production tax credits starting in 2025 under the Inflation Reduction Act.

They have completed constructing and operating six dairy digesters, a biogas pipeline spanning over 40 miles, a central facility to upgrade biogas to renewable natural gas, and a utility pipeline interconnection unit. The renewable natural gas is injected into the utility gas system and stored underground until Aemetis Biogas obtains carbon intensity (CI) pathway approvals from the California Air Resources Board (CARB) to sell credits under the California Low Carbon Fuel Standard.

They have already completed 90 days of renewable natural gas production and data collection required for the CARB approval process. While the final pathway is under review by CARB, Aemetis can use a temporary CI pathway with a value of -150, allowing them to start generating revenue in the third quarter of 2023.

To Discover the Inside Scoop on AMTX, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Andy Foster, the president of Aemetis Biogas Inc., expressed excitement about the approval of Aemetis Biogas for generating D3 RINs, as it marks a significant milestone towards generating full product revenue. He emphasized that the company’s investments since 2019 have directly reduced greenhouse gas pollution, improved air quality in Central Valley communities, and created jobs. Aemetis is committed to expanding their network of dairy digesters and producing more carbon-negative renewable natural gas to replace petroleum diesel.

The dairy digesters, pipeline project, and biogas-to-RNG facility funding includes grants from the California Department of Food and Agriculture and the California Energy Commission. Aemetis also closed a $25 million long-term financing deal with Greater Commercial Lending last fall, supported by a loan guarantee from the USDA. This project financing has a low fixed interest rate for the first five years and spans over 20 years.

Aemetis has plans to file applications for an additional $100 million of loans from the USDA’s REAP loan program. These funds will support the engineering, permitting, and construction of 31 more dairies. Each loan application will be limited to a maximum of $25 million and carry a 20-year repayment term.

https://twitter.com/Theweedfarmer/status/1658946668052504576?s=20

Where could Aemetis, Inc. (NASDAQ: AMTX) be in 5 years?

The company has an ambitious Five Year Plan to generate substantial revenue and reduce air and carbon pollution. The plan projects $2.0 billion in revenues, $496 million in net income, and $682 million in adjusted EBITDA by 2027, with strong compound annual growth rates. Aemetis aims to expand its operations by producing Renewable Natural Gas (RNG), Sustainable Aviation Fuel (SAF), Renewable Diesel fuel (RD), and other low-carbon products. The plan emphasizes the positive financial impact of the Inflation Reduction Act.

The plan highlights the financial benefits of the Inflation Reduction Act, which enables the transfer of tax credits and incentives related to production, projected to improve net income by $341 million in 2027.

The plan also focuses on revenue growth in all product lines, including expanding the dairy RNG business, constructing a renewable jet/diesel plant, implementing carbon sequestration, and improving energy efficiencies. 

The company has already achieved significant milestones, such as completing biogas pipeline construction, upgrading facilities for biogas-to-RNG production, and progressing in carbon sequestration and renewable jet/diesel plant development. The company has also secured a biodiesel purchase agreement in India and made strides in constructing a solar microgrid and implementing energy-efficient measures.

We will update you on AMTX when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by Leopold Böttcher from Pixabay

Continue Reading

Emerging Markets

GSI Technology, Inc. (NASDAQ: GSIT): Pure AI Play Transforming Semiconductor Memory Solutions for Efficient AI Processing

Published

3 weeks ago

on

May 14, 2023

By

GSI Technology, Inc. (NASDAQ: GSIT) has witnessed a significant surge in its stock price, from $1.62 to $3.84, at the time of writing on Friday, May 12.

GSI Technology, Inc. (NASDAQ: GSIT) has witnessed a significant surge in its stock price, from $1.62 to $3.84, at the time of writing on Friday, May 12. This represents an impressive 137% increase; the volume has been off the hook. If you look at their historical chart, $GSIT had meager volume, sometimes as low as 300 shares traded in a day. If you do the math, that’s less than $500 worth of shares traded in a day – safe to say it was virtually illiquid.

So what happened, and what drove the stock to trade 50M shares with filings or news releases?

After an in-depth examination, GSI Technology, Inc. appears to have experienced a notable turning point in its market trajectory. The catalyst for this transformation was the company’s prominent feature on Fox News, triggering an exponential dissemination of information across various platforms. It is worth highlighting an intriguing phenomenon that tends to transpire in such circumstances: purchasing shares often induces a ripple effect, encouraging further buying activity.

With Fox News bringing the company into the spotlight and stimulating investor interest, a domino effect occurred among astute day traders who eagerly seized the opportunity to partake in this promising venture. Consequently, the trading volume for GSI Technology, Inc. skyrocketed to unprecedented levels, surpassing all previously recorded thresholds.

This surge in volume stands as a testament to the immense enthusiasm that enveloped the market as traders recognized the tremendous potential inherent in $GSIT. This collective enthusiasm resulted in an extraordinary demonstration of market engagement, reflecting a widespread acknowledgment of the company’s significance and the opportunities it presents.

https://twitter.com/SamanthaLaDuc/status/1657033207412293634?s=20

This development showcases the power of influential media coverage and underscores the intriguing dynamics that can arise when investor sentiment aligns with a compelling market narrative.

To Discover the Inside Scoop on GSIT, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Founded in 1995, GSI Technology Inc. has established itself as a prominent provider of semiconductor memory solutions. The company is focused on introducing new products that capitalize on its core strengths, which include radiation-hardened memory products for extreme environments and Gemini, an advanced processing unit (APU) designed to enhance performance in various artificial intelligence (AI) applications. Headquartered in Sunnyvale, California, GSI Technology operates sales offices in the Americas, Europe, and Asia.

GSI Technology is on the verge of reporting its earnings next week, and the company operates in the storage business, which supports the development of highly efficient AI chips. Traditionally, computing involves separate chips for storage and computation, necessitating frequent data exchange. This process incurs significant power consumption and presents scalability challenges.

To address these limitations, GSI Technology has developed a groundbreaking solution called In-memory processing. This innovation substantially reduces computation time from minutes to seconds, milliseconds, or even microseconds. Notably, it also significantly diminishes power consumption and overall cost of ownership. The key to this improvement lies in the massive parallel data processing offered by GSI’s technology, featuring two million-bit processors per chip compared to thousands found in standard graphic processing units (GPUs). Consequently, the system becomes more scalable, enabling efficient and accelerated AI processing.

By streamlining the computing process and integrating storage and computation on a single chip, GSI Technology aims to revolutionize AI processing. This approach offers notable benefits regarding power efficiency, computational speed, and scalability, making it an attractive solution for a wide range of AI applications.

In conclusion, GSI Technology, Inc. is poised to deliver innovative semiconductor memory solutions emphasizing AI chip development. The company aims to reduce computation time, power consumption, and total ownership cost through its In-memory processing technology while significantly improving scalability. With its upcoming earnings report, investors and industry observers will closely watch the company’s progress in the storage business and AI chip development.

We will update you on GSIT when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening with GSIT.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by Gerd Altmann from Pixabay

Continue Reading

Trending

© All rights reserved.

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.